Medicinal Products

RoActemra

Name RoActemra
Active Substance tocilizumab
Prescription na recept
Type of prescription ograničeni recept (koncentrat za otopinu za infuziju, otopina za injekciju u napunjenoj štrcaljki)
Distribution u ljekarni
ATC Code L04AC07
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Vodič za zdravstvene radnike, verzija 5
Vodič za doziranje i primjenu lijeka, verzija 5
Educational materials
for patients / caregivers
Vodič za bolesnike, verzija 5
Kartica s upozorenjima za bolesnike, verzija 5

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/roactemra

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o rijetkom riziku od ozbiljnog oštećenja jetre kod primjene lijeka RoActemra (tocilizumab), uključujući akutno zatajenje jetre koje zahtijeva presađivanje 27.06.2019 Roche Registration GmbH
Back